IE32140B1 - Vaccines - Google Patents
VaccinesInfo
- Publication number
- IE32140B1 IE32140B1 IE713/68A IE71368A IE32140B1 IE 32140 B1 IE32140 B1 IE 32140B1 IE 713/68 A IE713/68 A IE 713/68A IE 71368 A IE71368 A IE 71368A IE 32140 B1 IE32140 B1 IE 32140B1
- Authority
- IE
- Ireland
- Prior art keywords
- informationally
- viruses
- antigen
- vaccines
- influenza
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
1,229,888. Vaccines. D. JACHERTZ. 19 June, 1968 [19 June, 1967], No. 29232/68. Heading A5B. Vaccines which are antigen-free and comprise aqueous suspensions of informationally active ribonucleic acid are prepared by stimulating with an antigen corresponding to the required informationally active RNA as system of immunologically competent cells or a cellfree system obtained therefrom, and isolating an aqueous suspension of the informationally active RNA. The vaccine may also contain an adjuvant such as aluminium hydroxide or phosphate and/or a pharmaceutically suitable carrier. The immunologically competent cells may be from human or animal lymphs, lymph nodes, spleen, peritoneal exudates and pheripheral leukocytes (blood). The antigen used may be from bacteria, viruses or their subunits or snake poison, e.g. tetanus and diphtheria toxin; the products of metabolism or degradation of Bordetella pertussio, Mycobacterlium tuberculosis, salmonellae, shigellae, brucellae; influenza, influenza haemagglutinim, polio viruses or their protein envelope, measles, rabies, foot and mouth disease, smallpox, swine fever, distemper, hepatitis contagiosa canis and encephalitis viruses.
[GB1229888A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEJ0033936 | 1967-06-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE32140L IE32140L (en) | 1968-12-19 |
| IE32140B1 true IE32140B1 (en) | 1973-04-18 |
Family
ID=7204943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE713/68A IE32140B1 (en) | 1967-06-19 | 1968-06-17 | Vaccines |
Country Status (13)
| Country | Link |
|---|---|
| AT (1) | AT282821B (en) |
| BE (1) | BE716806A (en) |
| BR (1) | BR6899970D0 (en) |
| CH (1) | CH513241A (en) |
| DE (1) | DE1617545C2 (en) |
| DK (1) | DK119724B (en) |
| ES (1) | ES355121A1 (en) |
| FR (2) | FR1588820A (en) |
| GB (1) | GB1229888A (en) |
| IE (1) | IE32140B1 (en) |
| IL (1) | IL30168A (en) |
| NL (1) | NL6808486A (en) |
| NO (1) | NO124840B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754934A (en) * | 1969-08-16 | 1971-02-17 | Jachertz Diether | RNA-MESSENGER ENZYMATIC PRODUCTION PROCESS |
| GB1594097A (en) | 1976-12-16 | 1981-07-30 | Int Inst Of Differentiation | Production of specific immune nucleic acids cell dialysates and antibodies |
| DE3115559A1 (en) * | 1981-04-16 | 1982-10-28 | Kommanditgesellschaft Schwarzhaupt, 5000 Köln | HIGH PURIFIED INFORMATIVE RIBONUCLEIC ACID (I-RNS), METHOD FOR THE PRODUCTION AND USE THEREOF |
| GB2216416B (en) * | 1988-03-11 | 1992-06-24 | Sandoz Ltd | Nucleobase source for the stimulation of the immune system |
| US6214804B1 (en) | 1989-03-21 | 2001-04-10 | Vical Incorporated | Induction of a protective immune response in a mammal by injecting a DNA sequence |
| US6673776B1 (en) | 1989-03-21 | 2004-01-06 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
| US6867195B1 (en) | 1989-03-21 | 2005-03-15 | Vical Incorporated | Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
-
1967
- 1967-06-19 DE DE1617545A patent/DE1617545C2/en not_active Expired
-
1968
- 1968-06-12 IL IL30168A patent/IL30168A/en unknown
- 1968-06-15 NO NO2340/68A patent/NO124840B/no unknown
- 1968-06-17 IE IE713/68A patent/IE32140B1/en unknown
- 1968-06-17 NL NL6808486A patent/NL6808486A/xx unknown
- 1968-06-17 CH CH893668A patent/CH513241A/en not_active IP Right Cessation
- 1968-06-17 AT AT576668A patent/AT282821B/en not_active IP Right Cessation
- 1968-06-18 DK DK286268AA patent/DK119724B/en unknown
- 1968-06-18 ES ES355121A patent/ES355121A1/en not_active Expired
- 1968-06-19 FR FR1588820D patent/FR1588820A/fr not_active Expired
- 1968-06-19 BR BR199970/68A patent/BR6899970D0/en unknown
- 1968-06-19 GB GB1229888D patent/GB1229888A/en not_active Expired
- 1968-06-19 BE BE716806D patent/BE716806A/xx unknown
- 1968-09-18 FR FR166589A patent/FR7781M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE1617545C2 (en) | 1983-11-03 |
| ES355121A1 (en) | 1969-11-16 |
| DE1617545A1 (en) | 1971-04-01 |
| NL6808486A (en) | 1968-12-20 |
| FR7781M (en) | 1970-03-23 |
| FR1588820A (en) | 1970-03-16 |
| BE716806A (en) | 1968-12-19 |
| BR6899970D0 (en) | 1973-02-13 |
| IL30168A0 (en) | 1968-08-22 |
| GB1229888A (en) | 1971-04-28 |
| IL30168A (en) | 1973-05-31 |
| AT282821B (en) | 1970-07-10 |
| IE32140L (en) | 1968-12-19 |
| DK119724B (en) | 1971-02-15 |
| CH513241A (en) | 1971-09-30 |
| NO124840B (en) | 1972-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wiktor et al. | Cultivation of rabies virus in human diploid cell strain WI-38 | |
| Oxford et al. | The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection | |
| Mumford et al. | Studies with inactivated equine influenza vaccine: 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8) | |
| Webster et al. | Potentiation of the immune response to influenza virus subunit vaccines | |
| Zygraich et al. | In vivo and in vitro properties of a temperature sensitive mutant of infectious bovine rhinotracheitis virus | |
| CA1045546A (en) | Highly attenuated cytomegalovirus vaccine and production thereof | |
| IE32140L (en) | Vaccine | |
| Atanasiu et al. | Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons: Part 3 | |
| US3927208A (en) | Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them | |
| Fekadu et al. | An immune stimulating complex (ISCOM) subunit rabies vaccine protects dogs and mice against street rabies challenge | |
| Glasgow et al. | Isoprinosine: lack of antiviral activity in experimental model infections | |
| Reiss et al. | Specificity of the helper T cell for the cytolytic T lymphocyte response to influenza viruses | |
| Holper et al. | Further studies on multiplication, serology and antigenicity of 2060 and JH viruses | |
| Barbour et al. | Comparison of Mycoplasma gallisepticum subunit and whole organism vaccines containing different adjuvants by western immunoblotting | |
| Norrby et al. | Humoral immunity to canine distemper after immunization of dogs with inactivated and live measles virus | |
| US3629413A (en) | Polyvalent bovine vaccines and methods of making and using same | |
| US5006335A (en) | Live vaccine against mumps and process for obtaining thereof | |
| Laver et al. | Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine | |
| Millian et al. | Antibody response of man to canine distemper virus | |
| McNeill | The antibody response of rabbits to inactivated vaccinia virus | |
| Luzzio | Demonstration of blood group substance A bound to Pasteurella pestis | |
| Musser et al. | Production of rubella virus vaccine: Live, attenuated in canine renal cell cultures | |
| McLaren et al. | Immunity to influenza in ferrets: XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization | |
| Srivastava et al. | Studies on the immunogenicity of Streptococcus equi vaccines in foals. | |
| Norrby | Characteristics of the progeny derived from multiplication of Sendai virus in a measles virus carrier cell line |